129 related articles for article (PubMed ID: 6191987)
21. [Enhancement of antitumor activity of bleomycin A5 in mouse sarcoma 180 cells in vitro and in vivo by verapamil].
He NG; Zhang HQ; Wang RH; Yang XL; Xue SB
Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):381-4. PubMed ID: 1716815
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms affecting peplomycin sensitivity of Chinese hamster cell lines.
Ozawa S; Tamura A; Suzuki H; Nishimura T; Tanaka N
J Antibiot (Tokyo); 1985 Sep; 38(9):1257-65. PubMed ID: 2415503
[TBL] [Abstract][Full Text] [Related]
23. Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.
Wassermann K; Zwelling LA; Lown JW; Hartley JA; Nishikawa K; Lin JR; Newman RA
Cancer Res; 1990 Mar; 50(6):1732-7. PubMed ID: 1689610
[TBL] [Abstract][Full Text] [Related]
24. [Effect of bleomycin A5 with calmodulin inhibitor on the proliferation of S-180 cells in vitro].
Zhang HQ; He NG; Xue SB
Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):470-3. PubMed ID: 1718143
[TBL] [Abstract][Full Text] [Related]
25. [Radiosensitizing effect of pepleomycin on the mouse].
Takahashi M; Ohta S; Shinoda M
Yakugaku Zasshi; 1985 Apr; 105(4):407-10. PubMed ID: 2410589
[No Abstract] [Full Text] [Related]
26. Potentiation of bleomycin cytotoxicity in cultured mammalian cells by high molecular weight polyacrylic acid.
Suzuki T; Kohda K; Kawazoe Y
Anticancer Res; 1990; 10(4):1001-4. PubMed ID: 1696443
[TBL] [Abstract][Full Text] [Related]
27. DNA strand scission in vivo and in vitro by auromomycin.
Suzuki H; Nishimura T; Tanaka N
Cancer Res; 1979 Jul; 39(7 Pt 1):2787-91. PubMed ID: 445483
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the response of synchronized HeLa cells to talisomycin and bleomycin.
Mirabelli CK; Crooke ST
Cancer Chemother Pharmacol; 1981; 5(4):251-6. PubMed ID: 6167377
[TBL] [Abstract][Full Text] [Related]
29. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
Tanaka N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
[TBL] [Abstract][Full Text] [Related]
31. Irradiation reduces bleomycin sensitivity in cervical squamous cancer cells in vitro.
Tanaka T; Yukawa K; Umesaki N
Eur J Gynaecol Oncol; 2007; 28(4):273-7. PubMed ID: 17713091
[TBL] [Abstract][Full Text] [Related]
32. Synergistic cell killing by antitumor agents and hyperthermia in cultured cells.
Mizuno S; Amagai M; Ishida A
Gan; 1980 Aug; 71(4):471-8. PubMed ID: 6159245
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic effect of pingyangmycin on cultured KB cells.
Tai KW; Chang YC; Chou LS; Chou MY
Oral Oncol; 1998 May; 34(3):219-23. PubMed ID: 9692057
[TBL] [Abstract][Full Text] [Related]
34. Involvement of the cellular vacuolar system with the cytotoxicity of bleomycin-like agents.
Lazo JS; Schisselbauer JC; Herring GM; Kennedy KA
Cancer Commun; 1990; 2(2):81-6. PubMed ID: 1695520
[TBL] [Abstract][Full Text] [Related]
35. The potentiation of the antitumor activity but not toxicity of bleomycin by 3-aminobenzamide.
Pan QC; Guo HY
J Antibiot (Tokyo); 1989 Dec; 42(12):1860-8. PubMed ID: 2482841
[TBL] [Abstract][Full Text] [Related]
36. Strand scission of deoxyribonucleic acid by neocarzinostatin, auromomycin, and bleomycin: studies on base release and nucleotide sequence specificity.
Takeshita M; Kappen LS; Grollman AP; Eisenberg M; Goldberg IH
Biochemistry; 1981 Dec; 20(26):7599-606. PubMed ID: 6173064
[TBL] [Abstract][Full Text] [Related]
37. Further characterization of bleomycin-resistant HeLa cells and analysis of resistance mechanism.
Urade M; Sugi M; Matsuya T
Jpn J Cancer Res; 1988 Apr; 79(4):491-500. PubMed ID: 2454906
[TBL] [Abstract][Full Text] [Related]
38. Arabinosyl nucleosides. XXXII. Mechanism of inhibition of L5178y mouse lymphoma cells by 9-beta-D-arabinofuranosylguanine.
Müller WE; Geurtsen W; Beyer R; Schuster DK; Zahn RK; Arendes J
Chem Biol Interact; 1981 Mar; 34(3):301-13. PubMed ID: 7460088
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the pulmonary toxicity and chemotherapeutic activity of bleomycin-BAPP to bleomycin and pepleomycin.
Ginsburg E; Gram TE; Trush MA
Cancer Chemother Pharmacol; 1984; 12(2):111-5. PubMed ID: 6199131
[TBL] [Abstract][Full Text] [Related]
40. Structures of cobalt(III)-pepleomycin and cobalt(III)-deglycopepleomycin (green forms) determined by NMR studies.
Caceres-Cortes J; Sugiyama H; Ikudome K; Saito I; Wang AH
Eur J Biochem; 1997 Mar; 244(3):818-28. PubMed ID: 9108252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
